Is VTRS stock a Buy, Sell, or Hold?

Based on our analysis, VTRS is currently a HOLD with moderate confidence. 📊 HOLD: VTRS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of VTRS stock?

Our analysis estimates the fair value range for VTRS to be between $13.43 and $15.52. The current price is $13.05.

What is the analyst price target for VTRS?

The average Wall Street analyst price target for VTRS is $15.72. This implies a potential upside of 20.5% from current levels.

VTRS Stock Analysis: Buy, Sell, or Hold?

VTRS - Viatris Inc. Common Stock

PHARMACEUTICAL PREPARATIONS

$13.05

-0.32 (-2.39%) ▼

5d: -1.14%

30d: -14.43%

90d: +5.85%

HOLD

MODERATE Confidence

Protect Your VTRS Gains

Analysis Updated: Mar 27, 2026 12:00 AM ET

Earnings: May 14, 2026

Smart Money Accumulation

VTRS is down 5.3% this week, but smart money is accumulating calls. Top strike: $15 2026-04-17 with 29,437 OI. Call ratio: 100% View Scanner →

Strength: 7.7/10

Get Alerted When VTRS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: VTRS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 8.8%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$19.18

Based on 6.4% avg growth

INTRINSIC VALUE TODAY

$11.91

Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.3x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: VTRS is currently trading at $13.05, which is considered oversold relative to its 30-day fair value range of $13.43 to $15.52. The stock's valuation (Forward PE: 4.9) is in line with its historical norms (5.3). Remarkably, the market is currently pricing in an annual earnings decline of 2.3% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, VTRS is in a strong uptrend. The price is currently testing key support at $13.05. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: VTRS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.72 (+20.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD

Fair Price Range $13.43 - $15.52

Company Quality Score 55/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 57.1%

Protect Your Profits

Holding VTRS? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
BEARISH: Weak technical setup (25/100)
BULLISH: High volume confirmation
BULLISH: Trading 20.5% below Wall St target ($15.72)

Fair Price Analysis

30-Day Fair Range $13.43 - $15.52

Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $13.05

Resistance Level $13.94

Current Trend Strong Uptrend

Technical data as of Mar 27, 2026

Fundamental Context

Forward P/E (Next Year Est.) 4.92

Wall Street Target $15.72 (+20.5%)

Revenue Growth (YoY) 5.0%

Earnings Growth (YoY) -70.6%

Profit Margin -24.6%

Valuation Discount vs History -2.3% cheaper

PE vs Historical 4.9 vs 5.3 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -2.3% (market-implied from PE analysis)

1-Year Target $12.75 (-2%)

2-Year Target $12.46 (-5%)

3-Year Target $12.17 (-7%)

3-Yr Target (if PE normalizes) (PE: 5→5) $13.12 (+1%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 22.4, Growth: 8.8%) $76.67 (+488%)

Base: (SPY PE: 4.9, Growth: 8.8%) $16.82 (+29%)

Bear: (PE: 4.2, Growth: 8.8%) $14.30 (+10%)

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 4.9 to 5.3

Stabilization Target: $14.07 (+7.8%)

PE Expansion Potential: +7.8%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: March 30, 2026 8:56 AM ET
Data refreshes hourly during market hours. Next update: 9:56 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is VTRS showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS BUYING

Recent Transactions

Gilbert Ray Cisneros, Jr. BUY 2025-11-18

David S Simmons BUY 213 shares 2025-11-03

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for VTRS.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
NBIX Neurocrine Biosciences I…	STRONG BUY 25 analysts	$178	62 BUY
ZTS Zoetis Inc	STRONG BUY 19 analysts	$151	55 HOLD
LNTH Lantheus Holdings Inc	STRONG BUY 13 analysts	$91	57 HOLD
BCRX BioCryst Pharmaceuticals…	STRONG BUY 12 analysts	$21	60 HOLD
HCM HUTCHMED DRC	STRONG BUY 14 analysts	$21	58 HOLD

NBIX Neurocrine Biosci…

62 BUY

ZTS Zoetis Inc

55 HOLD

LNTH Lantheus Holdings…

57 HOLD

BCRX BioCryst Pharmace…

60 HOLD

HCM HUTCHMED DRC

58 HOLD

Advanced VTRS Option Strategies

Professional options setups generated by AI based on today's VTRS price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for VTRS

VTRS Technical Chart VTRS Price Prediction VTRS Earnings Date VTRS Investment Advisor VTRS Fair Price Analyzer VTRS Options Advisor VTRS Options Chain VTRS Options Analysis VTRS Competitors

Compare VTRS with Other Stocks

PRAX vs VTRS
Winner: VTRS

CYRX vs VTRS

VTRS vs SNY

Create New Comparison

Tradestie